You are here

Entresto

Novartis files suit against IRA after blockbuster Entresto makes CMS' price negotiations list

Novartis files suit against IRA after blockbuster Entresto makes CMS' price negotiations list

Fierce Pharma

Inflation Reduction Act

Flag link:

Novartis hits back at Entresto selection on Medicare list

Novartis hits back at Entresto selection on Medicare list

Pharmaphorum

Flag link:

Novartis to appeal district court ruling on heart drug patent

Novartis to appeal district court ruling on heart drug patent

BioPharma Dive

Flag link:

Novartis' Entresto infringes on university patents, lawsuit claims

Novartis' Entresto infringes on university patents, lawsuit claims

Endpoints

Flag link:

Novartis petitions FDA to block 18 generic competitors for its megablockbuster heart drug until 2024

Novartis petitions FDA to block 18 generic competitors for its megablockbuster heart drug until 2024

Endpoints

Flag link:

ACC 2021: Novartis looks for silver linings in Entrestro’s narrow loss to an ACE inhibitor in heart attack patients

ACC 2021: Novartis looks for silver linings in Entrestro’s narrow loss to an ACE inhibitor in heart attack patients

Fierce Pharma

Flag link:

Novartis’ blockbuster heart med Entresto snags FDA approval in larger patient group

Novartis’ blockbuster heart med Entresto snags FDA approval in larger patient group

Fierce Pharma

Flag link:

Novartis' heart failure med Entresto wins FDA panel backing for bigger patient group—but just how much bigger?

Novartis' heart failure med Entresto wins FDA panel backing for bigger patient group—but just how much bigger?

Fierce Pharma

heart failure with preserved ejection fraction

Flag link:

ESC: Novartis' Entresto racks up a heart failure study win—but it's a mixed one

ESC: Novartis' Entresto racks up a heart failure study win—but it's a mixed one

Fierce Pharma

Flag link:

Novartis' Entresto gains steam with cardiologists despite stinging heart failure trial flop

Novartis' Entresto gains steam with cardiologists despite stinging heart failure trial flop

Fierce Pharma

Flag link:

AHA: Novartis hoping for second go at broader use with 'profound' Entresto subdata

AHA: Novartis hoping for second go at broader use with 'profound' Entresto subdata

Fierce Pharma

Flag link:

ESC: Novartis looks for the bright side in flopped Entresto heart failure study

ESC: Novartis looks for the bright side in flopped Entresto heart failure study

Fierce Pharma

clinical trials

European Society of Cardiology

Flag link:

5 Reasons Novartis Shareholders Aren't Shaken

5 Reasons Novartis Shareholders Aren't Shaken

Yahoo/Motley Fool

Flag link:

Novartis heart drug fails trial, curbing growth prospects

Novartis heart drug fails trial, curbing growth prospects

Yahoo/Reuters

clinical trials

Flag link:

American College of Cardiology Conference Roundup - day 1

American College of Cardiology Conference Roundup - day 1

CP Wire

American College of Cardiology

Edwards Lifesciences

clinical trials

atrial fibrillation

Flag link:

American College of Cardiology Conference Roundup - day 1

American College of Cardiology

Edwards Lifesciences

clinical trials

atrial fibrillation

Flag link:

Novartis builds its blockbuster case for Entresto, beating out a cheap ACE inhibitor in a head-to-head study

Novartis builds its blockbuster case for Entresto, beating out a cheap ACE inhibitor in a head-to-head study

Endpoints

Flag link:

Novartis (NVS) Q4 Earnings & Sales Top on Cosentyx, Entresto

Novartis (NVS) Q4 Earnings & Sales Top on Cosentyx, Entresto

NASDAQ.com

Flag link:

One big Novartis takeaway from Entresto's slow start? Heart failure doesn't work like oncology

One big Novartis takeaway from Entresto's slow start? Heart failure doesn't work like oncology

Fierce Pharma

Flag link:

Pages